Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation. - Wikidata - wikimedia - TriplyDB

Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation.

Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation.

http://www.wikidata.org/entity/Q34789015

about

Intermediate uveitis.Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes Current concepts and future directions in the pathogenesis and treatment of non-infectious intraocular inflammation.Mycophenolate mofetil for ocular inflammation.Ocular manifestation of rheumatoid arthritis-different forms and frequency A randomized clinical trial comparing methotrexate and mycophenolate mofetil for noninfectious uveitis.Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases Study.Treatment of Sarcoidosis.Success with single-agent immunosuppression for multifocal choroidopathies.Long-term daclizumab therapy for the treatment of noninfectious ocular inflammatory disease Long-term, multicenter evaluation of subconjunctival injection of triamcinolone for non-necrotizing, noninfectious anterior scleritis.Corticosteroid-sparing therapy: practice patterns among uveitis specialists Acute multifocal hemorrhagic retinal vasculitis in a child: a case report.Treatment of steroid-induced elevated intraocular pressure with anecortave acetate: a randomized clinical trial.Medication use in juvenile uveitis patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance Registry.Methotrexate for ocular inflammatory diseases.Azathioprine for ocular inflammatory diseases.Pharmacotherapy of scleritis: current paradigms and future directions.New molecular targets for the treatment of sarcoidosis.A review and update on orphan drugs for the treatment of noninfectious uveitis Clinical review: Anti-TNFalpha therapies in uveitis: perspective on 5 years of clinical experience.The role of biologic agents in the management of non-infectious uveitis.Susceptibility genes and pharmacogenetics in ocular inflammatory disorders.Cataract surgery in patients with history of uveitis.Emerging drugs for the treatment of uveitis.Ocular inflammatory diseases associated with rheumatoid arthritis.A comprehensive review and update on the non-biologic treatment of adult noninfectious uveitis: part I.Side-effects of anti-inflammatory therapy in uveitis.Non-Infectious Uveitis: Optimising the Therapeutic Response.Update on Treatment in Cardiac Sarcoidosis.A Bayesian Analysis of a Randomized Clinical Trial Comparing Antimetabolite Therapies for Non-Infectious Uveitis.Technology allows detection of target molecules and production of biologic agents for treatment of ocular inflammatory disorders.Pharmacologic Treatment of Noninfectious Uveitis.Intravitreal Adalimumab in Active Noninfectious Uveitis: A Pilot Study.Update on peripheral ulcerative keratitis Surveying uveitis specialists-a call for consensus.Immunosuppressive therapy for eye diseases: Effectiveness, safety, side effects and their prevention.Demographic, clinical, laboratory and treatment characteristics of spondyloarthritis patients with and without acute anterior uveitis.Efficacy and safety of immunomodulatory drugs in patients with anterior uveitis: A systematic literature review.Immunosuppression for the Uveitides.

P2860

Q24622474-1505C222-1316-4EE0-A909-ED6AC6EC537F Q26752297-F3AE8255-4EC0-41E5-9DA2-7A4E5794315F Q27693189-744BA69D-C0CD-4369-8A3C-DA7FCEC23865 Q33521396-A29E25E6-AC59-4B06-BCB7-A142F1AF0ED4 Q33847956-EEECCDE3-0FF5-491D-8019-FE84EC4AA613 Q34257553-9EE7FA0E-723C-4240-AA8C-CB806318C144 Q34444734-EB04A7BC-0CBE-4A34-A0BE-9997D75E2E38 Q34477003-0C668080-2E23-4C8F-B1D0-2F5C87168B20 Q34623981-C3AC3E8A-C258-4527-BC24-C67A812421C8 Q35215459-28738BEB-3C5E-4A4A-8BB2-6210C9D95A03 Q35250540-15A1DBD7-FCAC-4EA2-BF7F-16343117A3B9 Q35828102-0C75CDAA-0830-4D39-AB5A-7873CE65F9E3 Q36166779-D3092D78-7631-4F8B-8670-AB86972514E1 Q36421784-6C679C3A-4D9C-4FAE-A404-32988116C64B Q36584169-B097659B-A2FB-45DD-8BF6-0C5AB7A99CC6 Q37204512-0A6B4C83-D7D6-4AA5-A439-5CC45834D21E Q37366679-19B0C70F-4228-4ABE-AFDD-76475E935A47 Q37466204-82C3654E-0A8A-4A78-8339-0422833F9744 Q37494750-1FE2B6CF-B76B-430D-AD32-38D847576120 Q37632096-4985E8A5-2214-4322-BBC8-9977D783249A Q37650221-3B5B1932-0EC1-4692-8557-40AAF6E7FDB2 Q38025152-3685331C-72BB-4FEB-AB7B-6ACAC6D889E1 Q38043013-890AD3D5-C023-4BE4-8695-91518C72CF63 Q38130246-E880D259-6870-48BD-9B52-74B5CB467122 Q38166016-9895A664-4B64-4294-A287-0083D0542892 Q38169978-2BC9F595-7D9A-4DB8-8BA6-30455D174DC4 Q38250116-6CE1651B-6392-470B-9D24-1AC6D84CD33C Q38261127-00BD124F-B6B6-4C8E-B7F4-C0832DC93E86 Q38662045-EB633945-D7AF-4742-BA1D-7E0CE563FFC8 Q38802904-E8E078A8-7DC2-44ED-8DAF-54FEB9CE3BA1 Q40407231-6CDC184E-8BB5-461F-A5BE-35BA6F674627 Q40444244-0BA2AF0D-8F88-4868-B27F-C1D60A087BE2 Q40450258-B65DDB2F-8631-4EC8-AA10-CE815A799FEB Q41576239-5D56CE7C-9A23-4D2F-AC49-79DF32AC1108 Q41984399-0653BAA6-346B-4A15-AEA0-6FDEF7E2DFD9 Q42074249-A40C57D8-125F-4DF5-8C86-21786E107A14 Q42359937-E0D59CF6-A83B-4381-950D-3DDA746965C3 Q46033500-B389C290-02E5-4E72-A7E3-F8924579AC66 Q47378653-7CBE32E6-3D99-4CE8-9591-E035667B7C22 Q47932596-AF106572-7280-4E35-A5C7-7037CB961CBE

P2860

Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation.

http://www.wikidata.org/entity/Q34789015

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Comparison of antimetabolite d ...... nfectious ocular inflammation.

@ast

Comparison of antimetabolite d ...... nfectious ocular inflammation.

@en

Comparison of antimetabolite d ...... nfectious ocular inflammation.

@nl

type

label

Comparison of antimetabolite d ...... nfectious ocular inflammation.

@ast

Comparison of antimetabolite d ...... nfectious ocular inflammation.

@en

Comparison of antimetabolite d ...... nfectious ocular inflammation.

@nl

prefLabel

Comparison of antimetabolite d ...... nfectious ocular inflammation.

@ast

Comparison of antimetabolite d ...... nfectious ocular inflammation.

@en

Comparison of antimetabolite d ...... nfectious ocular inflammation.

@nl

P1433

Q34789015-DA5D9772-A03D-4B63-9F86-BEBA1659B8A0

P1476

Q34789015-B0B68528-54E8-44A1-8B00-E04C50E22D55

P2093

Q34789015-3633C17D-45C4-4AD1-9C22-0BE1859D4F00

Q34789015-42D7EE2D-B67C-48FD-94CE-00EB272E5445

Q34789015-4B0BD0EA-C68C-4955-BEC9-3F05D3D9F2AF

Q34789015-A7547C75-65CC-4076-A902-94C2CA4FFD1C

Q34789015-A910CDA5-6CD0-42E0-B6A2-E8663DB87001

Q34789015-E57FFF2B-4A34-4506-B1B9-94A1525F538E

Q34789015-EA3C8CEE-3FFB-41EA-BEEE-4F90C9DF8D3F

P304

Q34789015-7F7549FC-819A-49CC-821B-4D42292BC3AB

P31

Q34789015-94C522F8-3243-4C2C-BEE9-11F1E72FF01C

P356

Q34789015-56EF6E5D-67BA-4670-BD01-76C8A78CB3FA

P433

Q34789015-0AEF8E0E-D40E-490F-B2E9-B6C7C2DEE2A7

P478

Q34789015-F012B3F3-3A4E-4E0B-BC56-AAACAA06FF39

P577

Q34789015-F1CFB24A-F52D-46BD-B992-1803D7E49088

P698

Q34789015-255F561D-A363-48A1-B0A7-472409F87ABC

P921

Q34789015-04E01F1C-8F63-4B5E-88F8-BD1268707F98

P356

J.OPHTHA.2008.04.026

P1433

P1476

Comparison of antimetabolite d ...... nfectious ocular inflammation.

@en

P2093

Anat Galor

http://www.w3.org/2001/XMLSchema#string

Douglas A Jabs

http://www.w3.org/2001/XMLSchema#string

George B Peters

http://www.w3.org/2001/XMLSchema#string

Henry A Leder

http://www.w3.org/2001/XMLSchema#string

James P Dunn

http://www.w3.org/2001/XMLSchema#string

Jennifer E Thorne

http://www.w3.org/2001/XMLSchema#string

Sanjay R Kedhar

http://www.w3.org/2001/XMLSchema#string

P304

1826-1832

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.OPHTHA.2008.04.026

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P577

2008-06-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18579209

http://www.w3.org/2001/XMLSchema#string

P921